Christopher David Ozeroff

ORKA

Christopher David Ozeroff serves as S.V.P., General Counsel at Oruka Therapeutics, Inc. (ORKA). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$113.2K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$113.2K

Companies Traded

ORKA

Active Period

Nov 2021

1 total trades

Most Recent

Buy ORKA

Nov 23, 2021 · $113.2K

Christopher David Ozeroff's Insider Trading at Oruka Therapeutics, Inc. (ORKA)

Buys

1 · $113.2K

Sells

0 · $0.00

Total Shares Bought

50,000

Total Shares Sold

ORKA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Nov 23, 2021	Buy	50,000	$2.26	$113.2K	50,970

Related Insiders

Arjun Agarwal

officer: Senior Vice President, Finance

ORKASell · Jul 13, 2026

Laura Lee Sandler

officer: Chief Operating Officer

ORKASell · Jul 1, 2026

Fairmount Funds Management LLC

director, 10 percent owner:

ORKASell · Jul 1, 2026

Joana Goncalves

officer: Chief Medical Officer

ORKASell · Jun 15, 2026

Lawrence Otto Klein

director, officer: Chief Executive Officer

ORKASell · Jun 15, 2026

Paul T Quinlan

officer: General Counsel

ORKASell · Jun 15, 2026

Carl Dambkowski

director

ORKASell · Jun 12, 2026

Explore More Insider Trading Data

ORKA Insider Trading Activity

View all insider trades at Oruka Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity